AdvaMedDx Statement for 2013 Clinical Laboratory Public Meeting
application/pdf
- 39.28 kB
Date:
07/10/2013 Disease Area:
Comments
AdvaMedDx CY 2014 Clinical Laboratory Fee Schedule Preliminary Payment Determinations and MAAA Codes Comments
application/pdf
- 1.83 MB
Date:
10/25/2013 Disease Area:
AdvaMedDx Statement at CMS Clinical Laboratory Public Meeting July 2014
application/pdf
- 311.32 kB
Date:
07/14/2014 Disease Area:
Comments to FDA on Nucleic-Acid Based In Vitro Diagnostic Devices for the Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens
application/pdf
- 1.08 MB
Date:
06/18/2012 Disease Area:
Comments to FDA on CLIA Waiver Applications
application/pdf
- 528 kB
Date:
11/12/2012 Disease Area:
Comments to FDA on Highly Multiplex Microbiological/Medical Countermeasure In Vitro Nucleic Acid Based Diagnostic Devices
application/pdf
- 2.14 MB
Date:
02/07/2013 Disease Area:
Comments to FDA on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products
application/pdf
- 846.41 kB
Date:
03/18/2013 Disease Area:
Comments to FDA on Proposed Reclassification of Flu Tests
application/pdf
- 141.25 kB
Date:
08/20/2014 Disease Area:
Stakeholder Statements on the Regulation of Laboratory Developed Tests
application/pdf
- 94.77 kB
Date:
09/19/2014 Disease Area:
Comments to FDA on Staff-Flow Cytometric Devices
application/pdf
- 511.25 kB
Date:
01/05/2015 Disease Area: